The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Population pharmacokinetics of PQR309, a dual PI3K/mTOR inhibitor in adult patients with advanced solid tumors.

Matthias  Machacek

Employment - LYO-X GmbH

Leadership - LYO-X GmbH

Stock and Other Ownership Interests  - LYO-X GmbH; Novartis

Lionel  Renaud

Employment - Lyo-x GmbH

Sasa  Dimitrijevic

Employment - Piqur

Stock and Other Ownership Interests  - Novartis

Other Relationship - Piqur

Debora  Schmitz

Employment - Piqur

Stock and Other Ownership Interests  - Piqur

Research Funding - Friedrich-Miescher Institute/Novartis (Inst)

Travel, Accommodations, Expenses - Piqur

Elena  Ivanova

Employment - Piqur

Karin  Jorga

Employment - Roche/Genentech

Stock and Other Ownership Interests  - Roche/Genentech

Consulting or Advisory Role - Piqur